Intrinsic Value of S&P & Nasdaq Contact Us

OrthoPediatrics Corp. KIDS NASDAQ

NASDAQ Global Market • Healthcare • Medical - Devices • US • USD

SharesGrow Score
59/100
2/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$24.00
+34.4%
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

OrthoPediatrics Corp. (KIDS) has a negative trailing P/E of -9.4, meaning the company is currently unprofitable on a trailing twelve-month (TTM) basis. The forward P/E of 37.2 based on analyst estimates suggests a return to profitability is expected. Trailing earnings yield is -10.68%, forward earnings yield 2.69%.

Criteria proven by this page:

  • VALUE (96/100, Pass) — analyst target implies upside (+34.4%).
  • Forward P/E 37.2 — analysts expect a return to profitability with estimated EPS of $0.48 for FY2030.
  • Trailing Earnings Yield -10.68% — negative yield confirms the company is currently unprofitable. Investors are paying for a turnaround rather than current earnings. Forward yield improves to 2.69% as earnings recover.
  • Analyst consensus target $24.00 (+34.4% upside) — significant upside potential according to Wall Street analysts.

Overall SharesGrow Score: 59/100 with 2/7 criteria passed.

SharesGrow 7-Criteria Score
59/100
SG Score
View full scorecard →
VALUE
96/100
Price-to-Earnings & upside
Proven by this page
FUTURE
100/100
Analyst consensus
→ Forecast
PAST
25/100
→ Income
~
HEALTH
67/100
Debt-to-Equity & liquidity
→ Health
~
MOAT
54/100
→ Income
~
GROWTH
58/100
→ Income
INCOME
10/100
→ Income

Valuation Snapshot — KIDS

Valuation Multiples
P/E (TTM)-9.4
Forward P/E37.2
PEG RatioN/A
Forward PEGN/A
P/B Ratio1.07
P/S Ratio1.68
EV/EBITDA-54.2
Per Share Data
EPS (TTM)$-1.68
Forward EPS (Est.)$0.48
Book Value / Share$14.70
Revenue / Share$10.02
FCF / Share$-0.68
Yields & Fair Value
Earnings Yield-10.68%
Forward Earnings Yield2.69%
Dividend Yield0.00%
Analyst Target$24.00 (+34.4%)

Historical Valuation

Year P/E (TTM) PEG Ratio P/B Ratio P/S Ratio Dividend Yield
2016 -22.0 1.28 24.09 3.87 -
2017 -10.3 -0.09 1.95 2.03 6.45%
2018 -36.5 0.76 5.36 7.62 -
2019 -50.0 -2.18 4.83 9.47 -
2020 -22.6 -0.42 3.17 10.48 -
2021 -70.9 1.32 5.12 11.76 -
2022 653.9 -6.11 2.17 6.73 -
2023 -35.1 0.02 1.96 4.96 -
2024 -14.1 -0.18 1.51 2.61 -
2025 -10.5 -3.45 1.20 1.76 -

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2016 $-0.87 $37.3M $-6.57M -17.6%
2017 $-1.85 $45.62M $-8.93M -19.6%
2018 $-0.96 $57.56M $-12.03M -20.9%
2019 $-1.18 $72.55M $-17.2M -23.7%
2020 $-1.82 $71.08M $-32.94M -46.3%
2021 $-0.84 $98.05M $-16.26M -16.6%
2022 $0.06 $122.29M $1.26M 1%
2023 $-0.92 $148.73M $-20.97M -14.1%
2024 $-1.64 $204.73M $-37.82M -18.5%
2025 $-1.69 $236.35M $-39.65M -16.8%

Analyst Estimates

Year EPS (Avg) EPS Range Revenue (Avg) Revenue Range Analysts
2026 $-1.17 $-1.18 – $-1.17 $264.28M $263.92M – $264.64M 5
2027 $-0.79 $-0.79 – $-0.79 $295.64M $295.11M – $296.17M 5
2028 $-0.82 $-0.82 – $-0.82 $327.89M $326.79M – $329M 1
2029 $-0.01 $-0.01 – $-0.01 $368.7M $367.88M – $370.27M 1
2030 $0.48 $0.48 – $0.48 $410.8M $409.88M – $412.55M 1
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message